PDS Biotechnology
PDSB
PDSB
32 hedge funds and large institutions have $14.3M invested in PDS Biotechnology in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 14.14% → 14.13% (-0.01%)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$669K | |
| 3 | +$354K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$201K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$195K |
Top Sellers
| 1 | -$822K | |
| 2 | -$732K | |
| 3 | -$279K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$224K |
| 5 |
GAM
Gotham Asset Management
New York
|
-$219K |